World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
37585
World Ranking
6317
National Ranking
3367

Overview

Robert W. Buchanan is affiliated with the University of Maryland, Baltimore in the United States. Their research primarily spans the fields of Medicine, Neuroscience, and Psychology, with a strong focus on Psychiatry and Mental Health, Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging, Clinical Psychology, and Experimental and Cognitive Psychology.

The scientist's work concentrates on several principal topics, including Schizophrenia research and treatment, Functional Brain Connectivity Studies, Tryptophan and brain disorders, Advanced Neuroimaging Techniques and Applications, Mental Health Research Topics, Child and Adolescent Psychosocial and Emotional Development, and Autism Spectrum Disorder Research.

Notable recent publications by Robert W. Buchanan include:

  • Telepsychotherapy with youth at clinical high risk for psychosis: Clinical issues and best practices during the COVID-19 pandemic, 2020, Journal of Psychotherapy Integration
  • Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions, 2024, World Psychiatry
  • Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning, 2020, European Neuropsychopharmacology
  • Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants, 2020, Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  • Improving the predictive potential of diffusion MRI in schizophrenia using normative models-Towards subject-level classification, 2021, Human Brain Mapping

Robert W. Buchanan frequently collaborates with several researchers. Notable coauthors include Aristotle N. Voineskos, Anil K. Malhotra, Colin Hawco, James M. Gold, and Erin W. Dickie.

The scientist has published extensively in various academic venues. The most frequent publication venues include:

  • Schizophrenia Bulletin
  • Schizophrenia Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Biological Psychiatry
  • UNC Libraries

Best Publications

  • Physical Health Monitoring of Patients With Schizophrenia

    Stephen R. Marder;Susan M. Essock;Alexander L. Miller;Robert W. Buchanan

  • Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

    Oliver D. Howes;Rob McCutcheon;Ofer Agid;Andrea De Bartolomeis

  • The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

    Robert W. Buchanan;Julie Kreyenbuhl;Julie Kreyenbuhl;Deanna L. Kelly;Jason M. Noel

  • The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

    Kirkpatrick B;Buchanan Rw;McKenney Pd;Alphs Ld

  • A separate disease within the syndrome of schizophrenia.

    Brian Kirkpatrick;Robert W. Buchanan;David E. Ross;William T. Carpenter

  • The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003

    Anthony F. Lehman;Julie Kreyenbuhl;Robert W. Buchanan;Faith B. Dickerson

  • The neurological evaluation scale (NES): A structured instrument for the assessment of neurological signs in schizophrenia

    Robert W. Buchanan;Douglas W. Heinrichs

  • Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures.

    Alan Breier;Robert W. Buchanan;Ahmed Elkashef;Robert C. Munson

  • The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009

    Julie Kreyenbuhl;Robert W. Buchanan;Faith B. Dickerson;Lisa B. Dixon;Lisa B. Dixon

  • A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia

    Robert W Buchanan;Miriam Davis;Donald Goff;Michael F Green

  • Negative symptoms of schizophrenia: new developments and unanswered research questions

    Silvana Galderisi;Armida Mucci;Robert W Buchanan;Celso Arango;Celso Arango

  • Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

    Carol E Koro;Donald O Fedder;Gilbert J L'Italien;Sheila S Weiss

  • Significance and meaning of neurological signs in schizophrenia.

    Douglas W. Heinrichs;Robert W. Buchanan

  • The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments

    Robert W. Buchanan;Daniel C. Javitt;Stephen R. Marder;Nina R. Schooler

  • Persistent Negative Symptoms in Schizophrenia: An Overview

    Robert W. Buchanan

  • Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

    Alan Breier;Robert W. Buchanan;Brian Kirkpatrick;Orlando R. Davis

  • Initial phase 2 trial of a nicotinic agonist in schizophrenia.

    Robert Freedman;Ann Olincy;Robert W. Buchanan;Josette G. Harris

  • Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

    Gregory P. Strauss;William P. Horan;Brian Kirkpatrick;Bernard A. Fischer;Bernard A. Fischer

  • Structural Evaluation of the Prefrontal Cortex in Schizophrenia

    Robert W. Buchanan;Katalin Vladar;Patrick E. Barta;Godfrey D. Pearlson

  • Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, I : Sensitivity, reliability, and validity

    James M. Gold;Caleb Queern;Virginia N. Iannone;Robert W. Buchanan

Frequent Co-Authors

William T. Carpenter
William T. Carpenter University of Maryland, Baltimore
James M. Gold
James M. Gold University of Maryland, Baltimore
Alan Breier
Alan Breier Indiana University
Stephen R. Marder
Stephen R. Marder University of California, Los Angeles
Michael F. Green
Michael F. Green University of California, Los Angeles
Gregory P. Strauss
Gregory P. Strauss University of Georgia
Carol A. Tamminga
Carol A. Tamminga The University of Texas Southwestern Medical Center
Richard S.E. Keefe
Richard S.E. Keefe Duke University
Aristotle N. Voineskos
Aristotle N. Voineskos Centre for Addiction and Mental Health
Godfrey D. Pearlson
Godfrey D. Pearlson Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The path to a medical career in the USA is diverse, and online degrees now offer more flexible learning options than ever before. For nurses seeking leadership roles, there are cheapest online BSN to DNP programs that can help advance careers without the financial burden associated with traditional on-campus learning.

Students interested in pharmacy careers can explore the 3 year online PharmD route, which provides a streamlined, flexible option for earning a doctoral degree in pharmacy.

Not all medical careers require direct patient care. Those fascinated by health data can enroll in health information technology programs online to prepare for essential roles in medical records, informatics, and healthcare data management.

For those seeking a rapid entry into the healthcare workforce, becoming certified in medical coding is a practical choice. The growing demand for billing specialists makes the medical billing and coding certification cost and programs worth considering for a rewarding, flexible career.

Best Scientists Citing Robert W. Buchanan

Trending Scientists